Clinical significance of cyclin D1, fibroblast growth factor receptor 3, and p53 immunohistochemistry in plasma cell myeloma treated with a thalidomide-based regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples